The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships
| Autor: | Olgha Tarkhan-Mouravi, Amanda Bolster, Burmaa Alexander, Viengphone Khanthamaly, Nicolae Furtuna, Rachael M. Porter, Joshua A. Mott, Jeffrey McFarland, Nguyen Minh Hang, Gayane Sahakyan, Sonja J. Olsen, Marie Mazur, Cai Linlin, Marc-Alain Widdowson, Carmen S. Arriola, Phillip Muthoka, Philip L. Gould, Sonam Wangchuk, Vladimir Mikic, Gideon O. Emukule, Thoa Thi Minh Nguyen, Ann Moen, Susan Y. Chu, Jane F. Seward, Coulibaly Daouda, Alba Maria Ropero Alvarez, Pan Ruowen, Kathryn E. Lafond, Mirkhamudin Kamolzoda, Samantha Kluglein, Margaret McCarron, Dumitru Capmari, Sandra S. Chaves, Alan R. Hinman, Joseph S. Bresee, Erica Dueger, Malembe S. Ebama, Anonh Xeuatvongsa, Sara A. Mirza, Dominique Richardson, Mark A. McKinlay, Zhang Yongchao, Afif Bin Salah, Kristina Stavridis, Nga Ha Thu, Silvia Bino, Eduardo Azziz-Baumgartner, Dinagul Otorbaeva |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Program evaluation
Economic growth Influenza vaccine 030231 tropical medicine Advisory Committees Vaccination programs Public-Private Sector Partnerships Article 03 medical and health sciences Technical support 0302 clinical medicine Vaccine policy Influenza Human National Policy Humans 030212 general & internal medicine Program Development Developing Countries Disease burden General Veterinary General Immunology and Microbiology Immunization Programs Health Policy Vaccination Public Health Environmental and Occupational Health NITAG Infectious Diseases Influenza Influenza vaccine low and middle-income countries Influenza Vaccines General partnership Sustainability Molecular Medicine Business Program Evaluation |
| Zdroj: | Vaccine |
| ISSN: | 1873-2518 0264-410X |
| Popis: | Influenza vaccination remains the most effective tool for reducing seasonal influenza disease burden. Few Low and Middle-Income Countries (LMICs) have robust, sustainable annual influenza national vaccination programs. The Partnership for Influenza Vaccine Introduction (PIVI) was developed as a public-private partnership to support LMICs to develop and sustain national vaccination programs through time-limited vaccine donations and technical support. We review the first 5 years of experience with PIVI, including the concept, country progress toward sustainability, and lesson learned. Between 2013 and 2018, PIVI worked with Ministries of Health in 17 countries. Eight countries have received donated vaccines and technical support; of these, two have transitioned to sustained national support of influenza vaccination and six are increasing national support of the vaccine programs towards full transition to local vaccine program support by 2023. Nine additional countries have received technical support for building the evidence base for national policy development and/or program evaluation. PIVI has resulted in increased use of vaccines in partner countries, and early countries have demonstrated progress towards sustainability, suggesting that a model of vaccine and technical support can work in LMICs. PIVI expects to add new country partners as current countries transition to self-reliance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect